Rely on Radyus.

Whether you have an ad-hoc experiment or multiple preclinical studies in the pipeline, our team has the experience and a proven process to get you to your next milestone.

We work with biotech companies, academic startups and venture firms developing preclinical assets ranging from drug discovery, lead candidate selection, lead optimization and IND enabling studies.

We specialize in oncology, immunology, neuro/CNS, respiratory, metabolic and infectious diseases, across different modalities.